Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.54 |
| ▸ | TERT | O14746 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.37 |
| ▸ | TXN | P10599 | 1/20 | 0.37 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27232031 | 1.00 | TBXAS1 (0.54) | TBXAS1TERTTAAR1ALOX15HIF1A | |
| SCHEMBL439546 | 0.98 | TBXAS1 (0.51) | TBXAS1TERTTAAR1ALOX15HRH4 | |
| SCHEMBL441515 | 0.93 | TBXAS1 (0.49) | TBXAS1TERTTAAR1ALOX15HRH4 | |
| SCHEMBL441513 | 0.85 | TERT (0.47) | TBXAS1TERTTAAR1ALOX15TXN | |
| SCHEMBL28062565 | 0.84 | TBXAS1 (0.69) | TBXAS1TERTTAAR1ALOX15HTR1A | |
| SCHEMBL503743 | 0.84 | TBXAS1 (0.69) | TBXAS1TERTTAAR1ALOX15HTR1A | |
| Iodide SCHEMBL14645279 | 0.83 | TERT (0.46) | TBXAS1TERTTAAR1ALOX15TXN | |
| SCHEMBL3431746 | 0.82 | TBXAS1 (0.66) | TBXAS1TERTTAAR1ALOX15HTR1A | |
| SCHEMBL20000791 | 0.81 | TBXAS1 (0.46) | TBXAS1TERTTAAR1ALOX15HRH4 | |
| SCHEMBL23071637 | 0.79 | TBXAS1 (0.59) | TBXAS1TERTTAAR1ALOX15GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106187900-A | Method for preparing carboxylate ionic liquid and application of carboxylate ionic liquid | 南方科技大学 | 2016-12-07 | — | — | CN | disclosed |
| US-20120157701-A1 | PROCESS FOR PREPARING SILOXY CARBOXYLATES | BASF SE (DE) | 2012-06-21 | — | — | US | disclosed |
| US-20090023933-A1 | METHOD FOR ISOLATING ACIDS FROM CHEMICAL REACTION MIXTURES BY USING 1-ALKYLIMIDAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023933-A1 | METHOD FOR ISOLATING ACIDS FROM CHEMICAL REACTION MIXTURES BY USING 1-ALKYLIMIDAZOLES | POLL, INO80C, BRD7 | TBXAS1 2094/4885TERT 1193/4885TAAR1 2735/4885 |
| US-20120157701-A1 | PROCESS FOR PREPARING SILOXY CARBOXYLATES | IDH3A, IDH1, HDAC3 | TBXAS1 4428/4885TERT 2450/4885TAAR1 2500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.